ArticleJournal of addiction medicine2026
Development and Testing of a Peer Recovery Support Services Intervention for Retention on Medications for Opioid Use Disorder.
Article in Journal of addiction medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectivesThis study investigated the acceptability and preliminary efficacy of a peer recovery support services (PRSS) intervention focused on enhancing retention on medication for opioid use disorder (MOUD) through a pilot RCT.
methodsIndividuals on MOUD who were newly living in a recovery residence or a long-term residential program (ie, ASAM level 3.1) were randomized to either MOUD-focused PRSS or usual care only for 24 weeks (168 d). Negative binomial and logistic regression analyses using data from 40 adults (n=20 in PRSS and n=20 in TAU) tested for group differences on the primary outcome of cumulative days of MOUD adherence and secondary outcomes of other MOUD retention metrics, opioid use and return to regular use, and intervention acceptability assessed with an investigator-created satisfaction survey.
resultsResults revealed no group differences on primary or secondary outcomes, with those in PRSS reporting M=126 days of MOUD adherence compared with M=127 days in TAU. Overall satisfaction levels averaged 6.71 out of a possible 7.
conclusionsThe results of this study did not support our hypothesis that PRSS would enhance MOUD adherence; however, this is likely due to a ceiling effect. Participants from both groups had higher-than-expected MOUD adherence (∼75% of days). Participants who received the PRSS intervention rated it very highly, and notably, were not opposed to the integration of MOUD into PRSS. These results suggest that the PRSS intervention was acceptable and feasible, but that it should be further developed and tested for patients who face more barriers to MOUD retention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.